ART558
ART558 is a potent, selective and allosteric DNA polymerase theta (Polθ) inhibitor (IC50=7.9 nM) . ART558 elicits BRCA-gene synthetic lethality and DNA damage. ART558 can be used for the research of cancer, such as breast cancer[1].
Product Specifications
CAS Number
2603528-97-6
UNSPSC
12352005
Hazard Statement
H315, H319
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/art558.html
Purity
99.97
Solubility
DMSO : 170 mg/mL (ultrasonic)
Smiles
CN(C1=CC(C)=CC=C1)C([C@H]2N(C3=C(C(C(F)(F)F)=CC(C)=N3)C#N)CC[C@H]2O)=O
Molecular Formula
C21H21F3N4O2
Molecular Weight
418.41
Precautions
H315, H319
References & Citations
[1]Zatreanu D, et al. Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance. Nat Commun. 2021 Jun 17;12 (1) :3636.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-HOXC12 Antibody Picoband®, Dylight550 Conjugate
Biotin-Linked Monoclonal Antibody to Complement Component 3a (C3a)
Biotin-Linked Monoclonal Antibody to Complement Component 3a (C3a)
Biotin-Linked Monoclonal Antibody to Complement Component 3a (C3a)
Biotin-Linked Monoclonal Antibody to Complement Component 3a (C3a)